Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni DOT in HCV Patients on Opiate Substitution
NCT02638233Phase 4Unknown
- Sponsor
- Klinik Ottakring
- Start
- Sep 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C (HCV), sponsored by Klinik Ottakring. Status: unknown.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02638233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638233.